The Amrican Association of Immunologists (AAI) ANNOUNCES 2018-19 PUBLIC POLICY FELLOWS
AAI is launching the eighth year of its Public Policy Fellows Program (PPFP), which engages postdoctoral fellows and junior scientists in public policy activities that impact biomedical research. Read more..

NathanNathaniel H. Boyd, Ph.D.
University of Alabama at

UCEM director Marcas Bamman featured in TIME Magazinetime
Marcas Bamman, Ph.D., professor of Cell, Developmental and Integrative Biology and the director of the UAB Center for Exercise Medicine, was recently featured in the cover story of TIME Magazine. Pick up a print copy or click to read online (digital subscription required). 

Outstanding junior faculty recognized as 2018 Pittman Scholars
Five faculty members in the UAB School of Medicine have been named the 2018 class of James A. Pittman Jr., M.D., Scholars, a program created to recognize the contributions of junior faculty and support the recruitment and retention of highly competitive scientists and physician-scientists.
The Pittman Scholars, named for the late James A. Pittman, M.D., longtime dean of the School of Medicine from 1973 to 1992, are nominated by their department chairs based on their research achievements and their potential for continued discovery in the basic or clinical sciences. Pittman is considered a principal architect of the School for his ability to recruit top scientists and physicians to UAB.
Five Pittman Scholars are selected each academic year. The selected class of scholars receive $12,500 per year for five years to support the faculty member’s research-related activities or scholarly enrichment.

The 2018 Pittman Scholars are: Daniel Chu, M.D., Jodie Dionne-Odom, M.D., Jeremy Herskowitz, Ph.D., Anita Hjelmeland, Ph.D., and Kelly Hyndman, Ph.D.

In animal experiments, a human-derived glioblastoma significantly regressed Hjelmeland lab when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide. The regression seen in this combination therapy of temozolomide and the inhibitor SLC-0111 — which targets the enzyme carbonic anhydrase 9, or CA9 — was greater than that seen with either SLC-0111 or temozolomide alone, says research leader Anita Hjelmeland, Ph.D., assistant professor in the Department of Cell, Developmental and Integrative Biology at the University of Alabama at Birmingham.
Read More: Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

ultrasound pic Ultrasonography is an incredibly useful tool in medicine, particularly in emergency departments. It can be used to assess, usually in under a minute, whether a critically injured patient has time for a CT scan or needs to be rushed directly to the operating room. As the technology advances, it gets cheaper, more portable and more powerful, and because it uses sound waves, its use doesn’t put the patient at risk for radiation.
Read More: Ultrasound training prepares future physicians to provide better care


Body of Knowledge: Anatomy training gets a reboot

For more information regarding PKD Foundation please click the link below

Great News for CDIB 092016

MSBHS 2016